|
|
 Previous Article | Table of Contents | Next Article 
Blood, 1 July 2001, Vol. 98, No. 1, pp. 224-230
TRANSPLANTATION
Intravenous injection of apoptotic leukocytes enhances bone
marrow engraftment across major histocompatibility barriers
Marcelo de Carvalho Bittencourt,
Sylvain Perruche,
Emmanuel Contassot,
Stéphanie Fresnay,
Marie-Hélène Baron,
Régis Angonin,
François Aubin,
Patrick Hervé,
Pierre Tiberghien, and
Philippe Saas
From the Etablissement Français du Sang Bourgogne
Franche-Comté, UPRES EA2284-Université de
Franche-Comté, INSERM EO119 Besançon, France; Service
d'Anatomie Pathologique, CHU Besançon, France; Service de
Radiothérapie, CHU Besançon, France; and UPRES EA2085,
IETG, Université de Franche-Comté, Besançon, France.
Cross-tolerization of T lymphocytes after apoptotic cell uptake by
dendritic cells may be involved in self-tolerance maintenance. Furthermore, immunosuppressive properties are attributed to apoptotic cells. This study evaluated the consequences of apoptotic leukocyte administration in a restrictive engraftment model of murine bone marrow
(BM) transplantation. Sublethally irradiated recipients received a
limited number of allogeneic BM, with or without irradiated apoptotic
leukocytes of different origins. No graft-versus-host disease was
observed. Whereas only a low proportion of mice receiving BM cells
alone engrafted, addition of apoptotic irradiated leukocytes, independently of the origin (donor, recipient, third-party mice, as
well as xenogeneic peripheral blood mononuclear cells), significantly enhanced engraftment. Similar results were obtained after infusion of
leukocytes rendered apoptotic by UVB irradiation or by anti-Fas monoclonal antibody stimulation, thus confirming the role of apoptotic cells in engraftment facilitation. Overall, these results suggest that
apoptotic leukocytes can nonspecifically facilitate allogeneic BM
engraftment. Such a simple approach could be of interest in BM
transplantation settings involving an important HLA donor/recipient disparity, a T-cell-depleted graft, or reduced conditioning regimen intensity.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
C.-Q. Xia, R. Peng, Y. Qiu, M. Annamalai, D. Gordon, and M. J. Clare-Salzler
Transfusion of Apoptotic {beta}-Cells Induces Immune Tolerance to {beta}-Cell Antigens and Prevents Type 1 Diabetes in NOD Mice
Diabetes,
August 1, 2007;
56(8):
2116 - 2123.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Maeda, A. Schwarz, K. Kernebeck, N. Gross, Y. Aragane, D. Peritt, and T. Schwarz
Intravenous Infusion of Syngeneic Apoptotic Cells by Photopheresis Induces Antigen-Specific Regulatory T Cells
J. Immunol.,
May 15, 2005;
174(10):
5968 - 5976.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. R. Hoffmann, J. A. Kench, A. Vondracek, E. Kruk, D. L. Daleke, M. Jordan, P. Marrack, P. M. Henson, and V. A. Fadok
Interaction between Phosphatidylserine and the Phosphatidylserine Receptor Inhibits Immune Responses In Vivo
J. Immunol.,
February 1, 2005;
174(3):
1393 - 1404.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Garnache-Ottou, L. Chaperot, S. Biichle, C. Ferrand, J.-P. Remy-Martin, E. Deconinck, P. D. de Tailly, B. Bulabois, J. Poulet, E. Kuhlein, et al.
Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells
Blood,
February 1, 2005;
105(3):
1256 - 1264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Nakamura, M. Inaba, K. Sugiura, T. Yoshimura, A-H. Kwon, Y. Kamiyama, and S. Ikehara
Enhancement of Allogeneic Hematopoietic Stem Cell Engraftment and Prevention of GvHD by Intra-Bone Marrow Bone Marrow Transplantation Plus Donor Lymphocyte Infusion
Stem Cells,
March 1, 2004;
22(2):
125 - 134.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. E. Morelli, A. T. Larregina, W. J. Shufesky, A. F. Zahorchak, A. J. Logar, G. D. Papworth, Z. Wang, S. C. Watkins, L. D. Falo Jr, and A. W. Thomson
Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production
Blood,
January 15, 2003;
101(2):
611 - 620.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Ducoroy, O. Micheau, S. Perruche, L. Dubrez-Daloz, D. de Fornel, P. Dutartre, P. Saas, and E. Solary
LF 15-0195 immunosuppressive agent enhances activation-induced T-cell death by facilitating caspase-8 and caspase-10 activation at the DISC level
Blood,
January 1, 2003;
101(1):
194 - 201.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. H. Peranteau, S. Hayashi, M. Hsieh, A. F. Shaaban, and A. W. Flake
High-level allogeneic chimerism achieved by prenatal tolerance induction and postnatal nonmyeloablative bone marrow transplantation
Blood,
August 28, 2002;
100(6):
2225 - 2234.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Wilpshaar, M. Bhatia, H. H. H. Kanhai, R. Breese, D. K. Heilman, C. S. Johnson, J. H. F. Falkenburg, and E. F. Srour
Engraftment potential of human fetal hematopoietic cells in NOD/SCID mice is not restricted to mitotically quiescent cells
Blood,
June 17, 2002;
100(1):
120 - 127.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Stuart, M. Lucas, C. Simpson, J. Lamb, J. Savill, and A. Lacy-Hulbert
Inhibitory Effects of Apoptotic Cell Ingestion upon Endotoxin-Driven Myeloid Dendritic Cell Maturation
J. Immunol.,
February 15, 2002;
168(4):
1627 - 1635.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
